Patents by Inventor Stephen Boyle

Stephen Boyle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230286847
    Abstract: A water purification system provides clean water for the consumption by livestock by using a continuously recirculating water loop. A circulating pump moves the water and a particle filter system is fluidically connected in series. An ozone purification system is fluidically connected in parallel to a portion of the continuously recirculating feedback monitored and control water loop. The ozone purification system is disposed downstream of the particle filter system in relation to the flow direction. A feeding station is connected in series with the continuously recirculating water loop disposed downstream of the ozone purification system in relation to the flow direction. An alkaline water apparatus is disposed upstream of the ozone purification unit, connected either before or in parallel to the ozone purification system. A decrystallization process apparatus is connected to continuously solubilize gases of CO2, N2, and inert gases with the flowing water.
    Type: Application
    Filed: May 19, 2023
    Publication date: September 14, 2023
    Applicant: WET HOLDINGS (GLOBAL) LIMITED
    Inventors: Ahmed Abbas Mohamed, Stephen Boyle
  • Patent number: 11655172
    Abstract: A water purification system provides clean water for the consumption by livestock by using a continuously recirculating water loop. A circulating pump moves the water within the water loop in a flow direction. A particle filter system is fluidically connected in series and removes dissolved solids or particulates within the water. An ozone purification system and/or with the addition of other antimicrobial or purification agents is fluidically connected in parallel to a portion of the continuously recirculating feedback monitored and control water loop. The ozone purification system is disposed downstream of the particle filter system in relation to the flow direction. A feeding station is connected in series with the continuously recirculating water loop disposed downstream of the ozone purification system in relation to the flow direction. An alkaline water apparatus is disposed upstream of the ozone purification unit, connected either before or in parallel to the ozone purification system.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: May 23, 2023
    Assignee: WET Holdings (Global) Limited
    Inventors: Stephen Boyle, Ahmed Abbas Mohamed
  • Patent number: 10991016
    Abstract: A method and system for managing a plurality of credit card transactions within an integrated accounting environment. Embodiments of the present disclosure enable integration between financial institutions, organizational accounting systems, and disparate user workflows to overcome deficiencies of the prior art. Specific embodiments enable tracking of credit card charges, credits, and payments directly within an accounts payable interface, enabling the ability to view activity on the credit card account record, register, and vendor record. Methods and systems are operable to establish a real-time data transfer protocol between a financial institution and an organizational accounting application to integrate transaction data in real-time, define vendor association for transactions, and create a real-time credit card register to drive decision making across disparate user roles.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: April 27, 2021
    Assignee: Blackbaud, Inc.
    Inventors: Deborah Nelson, David Vroblesky, Nicole Guernsey, Julia Petit, David Epner, Stephen Boyle, Beth Kesser, Gautam Chawla, Rakesh Garg, Thomas Walker
  • Publication number: 20210009453
    Abstract: A water purification system provides clean water for the consumption by livestock by using a continuously recirculating water loop. A circulating pump moves the water within the water loop in a flow direction. A particle filter system is fluidically connected in series and removes dissolved solids or particulates within the water. An ozone purification system and/or with the addition of other antimicrobial or purification agents is fluidically connected in parallel to a portion of the continuously recirculating feedback monitored and control water loop. The ozone purification system is disposed downstream of the particle filter system in relation to the flow direction. A feeding station is connected in series with the continuously recirculating water loop disposed downstream of the ozone purification system in relation to the flow direction. An alkaline water apparatus is disposed upstream of the ozone purification unit, connected either before or in parallel to the ozone purification system.
    Type: Application
    Filed: September 22, 2020
    Publication date: January 14, 2021
    Applicant: Curozone Ireland Limited
    Inventors: Stephen Boyle, Ahmed Abbas Mohamed
  • Patent number: 10781118
    Abstract: A water purification system provides clean water for the consumption by livestock by using a continuously recirculating water loop. Optionally, a circulating pump moves the water within the water loop in a flow direction. A water supply inlet is fluidically connected to the water loop to provide additional water. A particle filter system (or systems) is fluidically connected in series and removes dissolved solids or particulates within the water. An ozone purification system and/or with the addition of other antimicrobial or purification agents is fluidically connected in parallel to a portion of the continuously recirculating feedback monitored and control water loop. The ozone purification system is disposed downstream of the particle filter system and RO (or similar) system in relation to the flow direction. A feeding station is connected in series with the continuously recirculating water loop disposed downstream of the ozone purification system in relation to the flow direction.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: September 22, 2020
    Assignee: CUROZONE IRELAND LIMITED
    Inventor: Stephen Boyle
  • Patent number: 10406219
    Abstract: Provided herein is a multivalent Brucella vaccine expressing at least one heterologous M. tuberculosis antigen. The vaccines described herein serve as an environmentally safe bivalent vaccine for protection against Brucella and Mycobacterium infections simultaneously. In particular, a multivalent vaccine comprising a Brucella strain transformed with a vector that expresses at least one M. tuberculosis antigen, where the M. tuberculosis antigen(s) is codon optimized for the Brucella strain is provided. In some aspects, the Brucella strain is B. abortus strain RB51 leuB and the M. tuberculosis antigen is one or more of Ag85B, Rv2660c, and ESAT6.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: September 10, 2019
    Assignee: Virginia Tech Intellectual Properties, Inc.
    Inventors: Sriranganathan Nammalwar, Hamzeh Al Qublan, Garrett Smith, Stephen Boyle, Gerhardt Schurig
  • Publication number: 20190244263
    Abstract: A method and system for managing a plurality of credit card transactions within an integrated accounting environment. Embodiments of the present disclosure enable integration between financial institutions, organizational accounting systems, and disparate user workflows to overcome deficiencies of the prior art. Specific embodiments enable tracking of credit card charges, credits, and payments directly within an accounts payable interface, enabling the ability to view activity on the credit card account record, register, and vendor record. Methods and systems are operable to establish a real-time data transfer protocol between a financial institution and an organizational accounting application to integrate transaction data in real-time, define vendor association for transactions, and create a real-time credit card register to drive decision making across disparate user roles.
    Type: Application
    Filed: February 8, 2019
    Publication date: August 8, 2019
    Inventors: Deborah Nelson, David Vroblesky, Nicole Guernsey, Julia Petit, David Epner, Stephen Boyle, Beth Kesser, Gautam Chawla, Rakesh Garg, Thomas Walker
  • Publication number: 20180009686
    Abstract: A water purification system provides clean water for the consumption by livestock by using a continuously recirculating water loop. Optionally, a circulating pump moves the water within the water loop in a flow direction. A water supply inlet is fluidically connected to the water loop to provide additional water. A particle filter system (or systems) is fluidically connected in series and removes dissolved solids or particulates within the water. An ozone purification system and/or with the addition of other antimicrobial or purification agents is fluidically connected in parallel to a portion of the continuously recirculating feedback monitored and control water loop. The ozone purification system is disposed downstream of the particle filter system and RO (or similar) system in relation to the flow direction. A feeding station is connected in series with the continuously recirculating water loop disposed downstream of the ozone purification system in relation to the flow direction.
    Type: Application
    Filed: July 10, 2017
    Publication date: January 11, 2018
    Inventor: Stephen Boyle
  • Publication number: 20170246282
    Abstract: Provided herein is a multivalent Brucella vaccine expressing at least one heterologous M. tuberculosis antigen. The vaccines described herein serve as an environmentally safe bivalent vaccine for protection against Brucella and Mycobacterium infections simultaneously. In particular, a multivalent vaccine comprising a Brucella strain transformed with a vector that expresses at least one M. tuberculosis antigen, where the M. tuberculosis antigen(s) is codon optimized for the Brucella strain is provided. In some aspects, the Brucella strain is B. abortus strain RB51 leuB and the M. tuberculosis antigen is one or more of Ag85B, Rv2660c, and ESAT6.
    Type: Application
    Filed: September 8, 2015
    Publication date: August 31, 2017
    Inventors: Sriranganathan NAMMALWAR, Hamzeh AL QUBLAN, Garrett SMITH, Stephen BOYLE, Gerhardt SCHURIG
  • Patent number: 8920803
    Abstract: A method for the treatment of a condition which is characterized by CD 123-expressing cells in a patient comprises administering to the patient (i) an antibody or antibody fragment which binds selectively to IL-3R?(CD 123), and (ii) an immunostimulating complex which comprises saponin, a sterol and a phospholipid.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: December 30, 2014
    Assignee: CSL Limited
    Inventors: Debra Pauline Drane, Eugene Maraskovsky, Jefferey Stephen Boyle
  • Publication number: 20130149303
    Abstract: A method for the treatment of a condition which is characterized by CD 123-expressing cells in a patient comprises administering to the patient (i) an antibody or antibody fragment which binds selectively to IL-3R?(CD 123), and (ii) an immunostimulating complex which comprises saponin, a sterol and a phospholipid.
    Type: Application
    Filed: June 15, 2011
    Publication date: June 13, 2013
    Applicant: CSL LIMITED
    Inventors: Debra Pauline Drane, Eugene Maraskovsky, Jefferey Stephen Boyle
  • Patent number: 8349575
    Abstract: The present invention provides a method and composition for raising an immune response in an animal. The method comprising administering to the animal a composition comprising a carrier and an antigen bound to a targeting moiety. The targeting moiety binds to at least one receptor that is upregulated on lymphocytes that home to MAdCAM+ mucosal lymphoid tissues.
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: January 8, 2013
    Assignee: The Council of the Queensland Institute of Medical Research (QIMR)
    Inventors: Brent Steven McKenzie, Jefferey Stephen Boyle, Andrew Mark Lew
  • Publication number: 20110165181
    Abstract: The present invention provides a method and composition for raising an immune response in an animal. The method comprising administering to the animal a composition comprising a carrier and an antigen bound to a targeting moiety. The targeting moiety binds to at least one receptor that is upregulated on lymphocytes that home to MAdCAM+ mucosal lymphoid tissues.
    Type: Application
    Filed: February 17, 2011
    Publication date: July 7, 2011
    Inventors: Brent Steven McKenzie, Jefferey Stephen Boyle, Andrew Mark Lew
  • Patent number: 7423016
    Abstract: The present invention provides methods of enhancing the immune response to an immunogen and to compositions for use in these methods. In particular the present invention provides a DNA molecule for use in raising an immune response to an antigen. The DNA molecule includes a first sequence encoding a targeting molecule, a second sequence encoding the antigen or an epitope thereof, and optionally a third sequence encoding a polypeptide which promotes dimerization or multimerization of the product encoded by the DNA molecule.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: September 9, 2008
    Assignee: CSL, Limited
    Inventors: Jeffrey Stephen Boyle, Jamie Louise Brady, Andrew Mark Lew
  • Patent number: 7423023
    Abstract: The present invention provides methods of enhancing the immune response to an immunogen and to compositions for use in these methods. In particular the present invention provides a DNA molecule for use in raising an immune response to an antigen. The DNA molecule includes a first sequence encoding a targeting molecule, a second sequence encoding the antigen or an epitope thereof, and optionally a third sequence encoding a polypeptide which promotes dimerization or multimerization of the product encoded by the DNA molecule.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: September 9, 2008
    Assignee: CSL, Limited
    Inventors: Jeffrey Stephen Boyle, Jamie Louise Brady, Andrew Mark Lew
  • Publication number: 20070036823
    Abstract: A recombinant, attenuated strain of Brucella suis with a deficiency in carboxyl-terminal protease (CtpA) activity can be used as a vaccine for the prevention or treatment of Brucellosis. Prior exposure to the Brucella species is identified by detecting a genetic sequence for carboxyl-terminal protease activity in a biological sample.
    Type: Application
    Filed: February 4, 2005
    Publication date: February 15, 2007
    Inventors: Aloka Bandara, Stephen Boyle, Nammalwar Sriranganathan, Gerhardt Schurig
  • Publication number: 20060093621
    Abstract: A recombinant, attenuated strain of Brucella suis or Brucella melitensis with a deficiency in carboxyl-terminal protease activity or tail-specific protease activity can be used as a vaccine for the prevention or treatment of Brucellosis. Prior exposure to the Brucella species is identified by detecting a genetic sequence for carboxyl-terminal (i.e. tail-specific) protease activity in a biological sample.
    Type: Application
    Filed: October 11, 2005
    Publication date: May 4, 2006
    Inventors: Aloka Bandara, Stephen Boyle, Nammalwar Sriranganathan, Gerhardt Schurig
  • Patent number: 6652326
    Abstract: A double-ended, coaxial contact assembly has a center probe rod (12) mounted in the bore of a dielectric center spacer bushing (16) and mounts a probe contact assembly on each end of the center probe rod. The center probe rod is received in a ground sleeve (19) with the probe contact assemblies maintained in coaxial relationship with the ground sleeve by a dielectric outer spacer bushing (17). In certain embodiments a movable ground plunger (18g,22) is slidably received in each end of the ground sleeves and biased outwardly by respective ground plunger coil springs (25). In one such embodiment the center spacer bushing (16′) is provided with an axially extending sleeve disposed between the respective probe contact assembly and the ground sleeve.
    Type: Grant
    Filed: July 11, 2001
    Date of Patent: November 25, 2003
    Assignee: Rika Electronics International, Inc.
    Inventors: Stephen A. Boyle, John C. Bergeron
  • Publication number: 20030072742
    Abstract: The present invention provides methods of enhancing the immune response to an immunogen and to compositions for use in these methods. In particular the present invention provides a DNA molecule for use in raising an immune response to an antigen. The DNA molecule includes a first sequence encoding a targeting molecule, a second sequence encoding the antigen or an epitope thereof, and optionally a third sequence encoding a polypeptide which promotes dimerization or multimerization of the product encoded by the DNA molecule.
    Type: Application
    Filed: June 28, 2002
    Publication date: April 17, 2003
    Applicant: Council of the Queensland Institute of Medical Research
    Inventors: Jeffrey Stephen Boyle, Jamie Louise Brady, Andrew Mark Lew
  • Publication number: 20030035793
    Abstract: The present invention provides methods of enhancing the immune response to an immunogen and to compositions for use in these methods. In particular the present invention provides a DNA molecule for use in raising an immune response to an antigen. The DNA molecule includes a first sequence encoding a targeting molecule, a second sequence encoding the antigen or an epitope thereof, and optionally a third sequence encoding a polypeptide which promotes dimerisation or multimerisation of the product encoded by the DNA molecule.
    Type: Application
    Filed: June 28, 2002
    Publication date: February 20, 2003
    Applicant: Council of the Queensland Institute of Medical Research
    Inventors: Jeffrey Stephen Boyle, Jamie Louise Brady, Andrew Mark Lew